Nobel Prize in medicine goes to trio for their work on immune tolerance
The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for their work on how our immune system is prevented from attacking our organs.
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
A trio of researchers has won the 2025 Nobel Prize in Physiology or Medicine for discovering how the immune system is prevented from attacking our own bodies.
Mary E. Brunkow of the Institute for Systems Biology in Seattle, Fred Ramsdell of Sonoma Biotherapeutics in San Francisco, and Shimon Sakaguchi of Osaka University in Japan were awarded the prize "for their discoveries concerning peripheral immune tolerance." The Nobel Assembly at Karolinska Institutet announced the winners at a ceremony in Stockholm, Sweden, on Monday (Oct. 6).
The three scientists' research, honored with the 116th medicine prize, provides insights into keeping the immune system under control to fight microbes and avoid autoimmune diseases.
"Their discoveries have been decisive for our understanding of how the immune system functions and why we do not all develop serious autoimmune diseases," Olle Kämpe, chair of the Nobel Committee, said in a statement.
Our immune system has to protect the body from a variety of harmful microbes, acting like a biological bodyguard. Some sneaky invaders, such as viruses, can mimic human cells, so part of the immune system's job is to determine who is on the guest list, while kicking out anything that shouldn't be there.
The new Nobel Prize winners revealed how our bodies use regulatory T cells to keep the immune system in check. Their work has launched a new field in peripheral tolerance research and led to the development of new medical treatments, including for cancer and autoimmune diseases.
Sakaguchi made the first key peripheral immune tolerance discovery in 1995, when many researchers thought that the immune system only developed tolerance through a process called central tolerance, during which harmful immune cells are dealt with in the thymus — a specialized organ in the chest that makes white blood cells.
Get the world’s most fascinating discoveries delivered straight to your inbox.
However, Sakaguchi demonstrated that the immune system has additional complexities by discovering immune cells, called regulatory T cells, that suppress overactive immune responses to protect the body's cells from autoimmune diseases.
These specialist cells keep an eye on other immune cells to ensure the immune system tolerates the body's natural tissues. In other words, they prevent our biological bodyguard from getting overzealous.
Brunkow and Ramsdell's contribution came six years later with their discovery that some mice had a gene mutation, named Foxp3, that makes them especially vulnerable to autoimmune diseases. The pair also found that alterations to the human version of this gene were responsible for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, an autoimmune disease.
In 2003, Sakaguchi demonstrated that the Foxp3 gene is responsible for governing the development of regulatory T cells.
Stay tuned for more Nobel Prize announcements this week. The next announcement will be on Tuesday (Oct. 7), when we'll learn who is awarded the 2025 Nobel Prize for Physics.

Patrick Pester is the trending news writer at Live Science. His work has appeared on other science websites, such as BBC Science Focus and Scientific American. Patrick retrained as a journalist after spending his early career working in zoos and wildlife conservation. He was awarded the Master's Excellence Scholarship to study at Cardiff University where he completed a master's degree in international journalism. He also has a second master's degree in biodiversity, evolution and conservation in action from Middlesex University London. When he isn't writing news, Patrick investigates the sale of human remains.
You must confirm your public display name before commenting
Please logout and then login again, you will then be prompted to enter your display name.
